These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 2008909)

  • 1. Significance of glycosaminoglycans for the formation of calcium oxalate stones.
    Hesse A; Wuzel H; Vahlensieck W
    Am J Kidney Dis; 1991 Apr; 17(4):414-9. PubMed ID: 2008909
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The excretion of glycosaminoglycans in the urine of calcium-oxalate-stone patients and healthy persons.
    Hesse A; Wuzel H; Vahlensieck W
    Urol Int; 1986; 41(2):81-7. PubMed ID: 3727195
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Investigation of GAGS on 24-hour and 2-hour urines from calcium oxalate stone formers and healthy subjects.
    Gianotti M; Genestar C; Palou A; Pons A; Conte A; Grases F
    Int Urol Nephrol; 1989; 21(3):281-8. PubMed ID: 2807779
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Urate and calcium oxalate stones: from repute to rhetoric to reality.
    Grover PK; Ryall RL
    Miner Electrolyte Metab; 1994; 20(6):361-70. PubMed ID: 7783698
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Urinary glycosaminoglycans are selectively included into calcium oxalate crystals precipitated from whole human urine.
    Suzuki K; Mayne K; Doyle IR; Ryall RL
    Scanning Microsc; 1994; 8(3):523-30. PubMed ID: 7747154
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dietary treatment of urinary risk factors for renal stone formation. A review of CLU Working Group.
    Prezioso D; Strazzullo P; Lotti T; Bianchi G; Borghi L; Caione P; Carini M; Caudarella R; Ferraro M; Gambaro G; Gelosa M; Guttilla A; Illiano E; Martino M; Meschi T; Messa P; Miano R; Napodano G; Nouvenne A; Rendina D; Rocco F; Rosa M; Sanseverino R; Salerno A; Spatafora S; Tasca A; Ticinesi A; Travaglini F; Trinchieri A; Vespasiani G; Zattoni F;
    Arch Ital Urol Androl; 2015 Jul; 87(2):105-20. PubMed ID: 26150027
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative study of the circadian rhythmicity in the urinary concentration of glycosaminoglycans in patients of calcium oxalate nephrolithiasis and in healthy adults.
    Sidhu H; Thind SK; Nath R; Vaidyanathan S; Hemal AK; Mandal AK; Krishan K
    Urol Int; 1989; 44(4):218-21. PubMed ID: 2800054
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Calcium oxalate crystallization in urine: role of urate and glycosaminoglycans.
    Grover PK; Ryall RL; Marshall VR
    Kidney Int; 1992 Jan; 41(1):149-54. PubMed ID: 1593851
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Urinary glycosaminoglycan excretion in healthy and stone-forming children.
    Harangi F; Györke Z; Melegh B
    Pediatr Nephrol; 1996 Oct; 10(5):555-8. PubMed ID: 8897554
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glycosaminoglycans in urine and extracorporeal shock wave lithotripsy.
    Winter P; Ganter K; Leppin U; Schoeneich G; Hesse A
    Urol Res; 1995; 23(6):401-5. PubMed ID: 8788280
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Urate and calcium stones--picking up a drop of mercury with one's fingers?
    Ryall RL; Grover PK; Marshall VR
    Am J Kidney Dis; 1991 Apr; 17(4):426-30. PubMed ID: 2008911
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Urate metabolism and renal calcium stone disease.
    Fellström B
    Scand J Urol Nephrol Suppl; 1981; 62():1-59. PubMed ID: 6960474
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibitory activity of whole urine: a comparison of urines from stone formers and healthy subjects.
    Ryall RL; Hibberd CM; Mazzachi BC; Marshall VR
    Clin Chim Acta; 1986 Jan; 154(1):59-67. PubMed ID: 3943225
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Surface interaction between glycosaminoglycans and calcium oxalate.
    Angell AH; Resnick MI
    J Urol; 1989 May; 141(5):1255-8. PubMed ID: 2709520
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Urinary glycosaminoglycans and glycoproteins in a calcium oxalate crystallization system.
    Poon NW; Gohel MD
    Carbohydr Res; 2012 Jan; 347(1):64-8. PubMed ID: 22119438
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modulatory effect of the 23-kD calcium oxalate monohydrate binding protein on calcium oxalate stone formation during oxalate stress.
    Asokan D; Kalaiselvi P; Varalakshmi P
    Nephron Physiol; 2004; 97(1):p23-30. PubMed ID: 15153748
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Pathophysiology, diagnosis and conservative therapy in calcium kidney calculi].
    Hess B
    Ther Umsch; 2003 Feb; 60(2):79-87. PubMed ID: 12649986
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Calcium oxalate stone formation in genetic hypercalciuric stone-forming rats.
    Bushinsky DA; Asplin JR; Grynpas MD; Evan AP; Parker WR; Alexander KM; Coe FL
    Kidney Int; 2002 Mar; 61(3):975-87. PubMed ID: 11849452
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Mineralogical composition of urinary stones, risk factors and metabolic disturbances in patients with calcium-oxalate urolithiasis].
    Kustov AV; Strelnikov AI; Moryganov MA; Airapetyan AO; Smirnov PR; Lyalyakina EV; Toms SR
    Urologiia; 2017 Sep; (4):22-26. PubMed ID: 28952687
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oxalate metabolism in renal stone disease with special reference to calcium metabolism and intestinal absorption.
    Lindsjö M
    Scand J Urol Nephrol Suppl; 1989; 119():1-53. PubMed ID: 2669121
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.